Clinical Trials

1,263 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06341387 2024-04-02

Volatolomic and Proteomic Profile for Early Diagnosis of Lung Cancer

200 enrolled

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms

NCT06342323 2024-04-02

ONFM-SBRT

GastrointestinalGenitourinaryThoracic

57 enrolled

Carcinoma, Renal Cell, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT06335290 2024-03-28

Radiotherapy Treatments for the Treatment of Thoracic District Tumors

13,200 enrolled

Thoracic Neoplasms

NCT05775068 2024-03-27

ARGOS

2,000 enrolled

Lung Neoplasms

NCT06323265 2024-03-27

A Real-world Study of Adebrelimab Combined With Chemotherapy±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer

50 enrolled

Extensive Stage Small Cell Lung Cancer

NCT06326086 2024-03-22

Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.

240 enrolled

Carcinoma, Non-Small-Cell Lung, Sarcopenia

NCT06321640 2024-03-20

POSITive

BreastDermatologicGastrointestinalGenitourinaryHead & NeckThoracic

265 enrolled

Breast Neoplasms, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

NCT06310915 2024-03-15

Oral Chemotherapeutic Drugs Were Analyzed in Patients With Driver Gene Negative Locally Advanced/Advanced Non-small Cell Lung Cancer With PS Score 2 A Prospective, Single-arm, Multicenter, Observational Study on the Efficacy and Safety of Radiochemotherapy Combined With PD-1 Inhibitor

Non-small Cell Lung Cancer Stage IIIB/IV

NCT06285058 2024-03-13

Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant Immunochemotherapy

1,000 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06102369 2024-03-06

The Role of Narrow Band Imaging (NBI) Bronchoscopy in Detecting Bronchial Squamous Dysplasia in Lung Cancer

110 enrolled

Lung Neoplasms

NCT06287320 2024-03-01

The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer

200 enrolled

Locally Advanced Non-small Cell Lung Cancer

NCT06282068 2024-02-28

AI Determine Malignancy of GGO on Chest CT

100 enrolled

Lung Neoplasms

NCT06275178 2024-02-23

Medical Thoracoscopy for Diagnosing Unexplained Pleural Effusion: a National Multicenter Retrospective Study

5,000 enrolled

Pleural Effusion, Pleural Effusion, Malignant

NCT06267144 2024-02-20

Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer

20 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06267170 2024-02-20

SCLC

288 enrolled

SCLC,Extensive Stage

NCT06259461 2024-02-14

Machine Learning to Construct an Association Model for Lung Cancer and Environmental Hormone

128 enrolled

Lung Neoplasms

NCT06245876 2024-02-12

Lung EpiCheck Biomarkers Development Study

6,000 enrolled

Lung Neoplasms

NCT06255041 2024-02-12

Detection of Cancer in Breath Samples by Trained Detection Dogs

BreastGastrointestinalGenitourinaryThoracic

1,250 enrolled

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT06250829 2024-02-09

Pre-PLaN

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06251570 2024-02-09

Evaluation of Dual Task Performance and Respiratory Muscle Endurance in Patients With Lung Cancer

60 enrolled

Lung Neoplasms

NCT02049645 2024-02-08

The Suitability of Sniff Dog as a Tool in Screening Tumors

4,000 enrolled

BreastThoracic

Breast Neoplasms, Lung Neoplasms, Neoplasms

NCT05526573 2024-02-02

Diagnostic Yeld of Ultrathin Bronchoscopy in Peripheral Pulmonary Lesions

148 enrolled

Adenocarcinoma of Lung, Lung Diseases, Lung Neoplasms, Tuberculosis, Pulmonary

NCT04823741 2024-02-01

SCITH-MESO

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT06228508 2024-01-29

BiliBro

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06222190 2024-01-24

Lung_Cancer_adaptive - Ethos

Lung Neoplasms

NCT06220305 2024-01-23

MAGIC

100 enrolled

Lung Cancer Diagnosis

NCT05987189 2024-01-16

Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung

2,000 enrolled

Lung Neoplasms

NCT04191174 2024-01-05

Ventilation Heterogeneity Prior to Lung Resection

115 enrolled

Lung Neoplasms

NCT04789252 2024-01-02

TUM-DC

64 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Neoplasms

NCT03646994 2023-12-27

Real World Study on First Line Crizotinib in ROS1 Rearranged Advanced Non-squamous Non-small Cell Lung Cancer

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03647111 2023-12-27

Real World Study of First Line Crizotinib for ALK Rearranged Non-squamous Non-small Cell Lung Cancer

120 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03647592 2023-12-27

Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT04322591 2023-12-27

POSEIDON

70 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04397432 2023-12-27

SELECT-1

878 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05991180 2023-12-27

Real-World Study on the Efficacy of IBI-322 in Combination With Lenvatinib for the Treatment of Extensive Stage Small Cell Lung Cancer

160 enrolled

Small Cell Lung Carcinoma

NCT06180239 2023-12-22

Segmentectomy vs Lobectomy

800 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06163846 2023-12-20

Image Mining and ctDNA to Improve Risk Stratification and Outcome Prediction in NSCLC Applying Artificial Intelligence.

415 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06174857 2023-12-18

Efficacy of Osimertinib in Patients With Lung Cancer

100 enrolled

Advanced Non-Small Cell Lung Cancer

NCT05542485 2023-12-15

PLAN

97 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03840928 2023-12-13

PatientSpot Formerly Known as ArthritisPower

CNSDermatologicOtherThoracic

40,000 enrolled

Intervertebral disc disease, Undifferentiated Connective Tissue Diseases, Axial Spondyloarthritis, Alopecia, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Angina, Unstable, Arrhythmias, Cardiac, Arthritis, Juvenile, Arthritis, Rheumatoid, Asthma, Ataxia, Brain Neoplasms, Intracranial Aneurysm, Cluster Headache, Crohn Disease, Cystic Fibrosis, Dermatomyositis, Diabetes Mellitus, Hyperostosis, Diffuse Idiopathic Skeletal, Eczema, Epilepsy, Fibromyalgia, Gout, Craniocerebral Trauma, Headache, Heart Defects, Congenital, Heart Failure, Heart Valve Diseases, Hydrocephalus, Hypertension, Lung Neoplasms, Meningitis, Multiple Sclerosis, Muscular Dystrophies, Myocardial Infarction, Myositis, Obesity, Osteoarthritis, Osteoporosis, Parkinson Disease, Polychondritis, Relapsing, Polymyalgia Rheumatica, Psoriasis, Sleep Apnea Syndromes, Spinal Cord Injuries, Spondylitis, Ankylosing, Giant Cell Arteritis, Granulomatosis with Polyangiitis, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Polymyositis, Tension-Type Headache, Guillain-Barre Syndrome, Bell Palsy, Stroke, Neurocutaneous Syndromes, Pulmonary Disease, Chronic Obstructive, Scleroderma, Diffuse, Peripheral Arterial Disease

NCT04636775 2023-12-11

Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)

46 enrolled